share_log

Allegro Microsystems Analyst Ratings

Benzinga ·  Sep 29, 2023 11:35
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/29/2023 11.53% B of A Securities → $36 Initiates Coverage On → Neutral
08/09/2023 54.91% Needham → $50 Reiterates Buy → Buy
08/02/2023 54.91% Needham → $50 Reiterates Buy → Buy
07/26/2023 85.89% Wells Fargo $52 → $60 Maintains Overweight
07/20/2023 73.5% Mizuho $50 → $56 Maintains Buy
07/20/2023 85.89% Barclays $50 → $60 Maintains Overweight
07/20/2023 Wolfe Research Initiates Coverage On → Peer Perform
05/12/2023 54.91% Mizuho $48 → $50 Maintains Buy
05/12/2023 54.91% Needham → $50 Reiterates Buy → Buy
03/15/2023 54.91% Needham $42 → $50 Maintains Buy
03/15/2023 54.91% Barclays $44 → $50 Maintains Overweight
02/01/2023 36.32% Cowen & Co. $38 → $44 Maintains Outperform
02/01/2023 36.32% Barclays $32 → $44 Maintains Overweight
02/01/2023 30.12% Mizuho $38 → $42 Maintains Buy
02/01/2023 30.12% Needham $30 → $42 Maintains Buy
01/23/2023 -0.86% Barclays $26 → $32 Maintains Overweight
01/20/2023 17.73% Cowen & Co. $30 → $38 Maintains Outperform
01/09/2023 8.44% Wells Fargo $30 → $35 Maintains Overweight
10/28/2022 17.73% Mizuho $42 → $38 Maintains Buy
10/27/2022 -7.05% Needham $27 → $30 Maintains Buy
07/29/2022 -16.35% Needham $25 → $27 Maintains Buy
07/25/2022 -19.45% Barclays $31 → $26 Maintains Overweight
07/11/2022 -7.05% Wells Fargo $35 → $30 Maintains Overweight
05/25/2022 -7.05% Cowen & Co. → $30 Initiates Coverage On → Outperform
05/11/2022 30.12% Mizuho $44 → $42 Maintains Buy
05/11/2022 -3.96% Needham $40 → $31 Maintains Buy
04/25/2022 -3.96% Barclays $35 → $31 Maintains Overweight
04/20/2022 36.32% Mizuho $45 → $44 Maintains Buy
10/29/2021 23.93% Credit Suisse $36 → $40 Maintains Outperform
10/29/2021 17.73% Barclays $30 → $38 Maintains Overweight
10/29/2021 23.93% Needham $35 → $40 Maintains Buy
09/21/2021 17.73% Wells Fargo $36 → $38 Maintains Overweight
07/30/2021 23.93% Mizuho $38 → $40 Maintains Buy
06/30/2021 William Blair Initiates Coverage On → Outperform
02/09/2021 8.44% Needham $27 → $35 Maintains Buy
02/08/2021 11.53% Credit Suisse $27 → $36 Maintains Outperform
11/23/2020 -7.05% SMBC Nikko → $30 Initiates Coverage On → Outperform
11/23/2020 -16.35% Credit Suisse → $27 Initiates Coverage On → Outperform
11/23/2020 -13.25% Mizuho → $28 Initiates Coverage On → Buy
11/23/2020 -13.25% Jefferies → $28 Initiates Coverage On → Buy
11/23/2020 -16.35% Needham → $27 Initiates Coverage On → Buy

What is the target price for Allegro Microsystems (ALGM)?

The latest price target for Allegro Microsystems (NASDAQ: ALGM) was reported by B of A Securities on September 29, 2023. The analyst firm set a price target for $36.00 expecting ALGM to rise to within 12 months (a possible 11.53% upside). 20 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Allegro Microsystems (ALGM)?

The latest analyst rating for Allegro Microsystems (NASDAQ: ALGM) was provided by B of A Securities, and Allegro Microsystems initiated their neutral rating.

When is the next analyst rating going to be posted or updated for Allegro Microsystems (ALGM)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Allegro Microsystems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Allegro Microsystems was filed on September 29, 2023 so you should expect the next rating to be made available sometime around September 29, 2024.

Is the Analyst Rating Allegro Microsystems (ALGM) correct?

While ratings are subjective and will change, the latest Allegro Microsystems (ALGM) rating was a initiated with a price target of $0.00 to $36.00. The current price Allegro Microsystems (ALGM) is trading at is $32.28, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment